Bionano Genomics Inc
(BNGO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,104 | 5,091 | 28,166 | 27,159 | 24,048 |
| Marketable Securities | 91,704 | 108,095 | 152,024 | 160,178 | 192,420 |
| Receivables | 6,780 | 7,022 | 5,829 | 4,851 | 5,514 |
| Inventories | 33,113 | 29,761 | 25,046 | 20,591 | 16,268 |
| TOTAL | $142,557 | $157,298 | $218,197 | $216,288 | $242,360 |
| Non-Current Assets | |||||
| PPE Net | 19,050 | 18,029 | 15,859 | 13,923 | 12,661 |
| Intangibles | 116,640 | 118,432 | 79,051 | 80,259 | 81,678 |
| Other Non-Current Assets | 13,904 | 13,743 | 10,591 | 11,082 | 11,512 |
| TOTAL | $149,594 | $150,204 | $105,501 | $105,264 | $105,851 |
| Total Assets | $292,151 | $307,502 | $323,698 | $321,552 | $348,211 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 15,780 | 12,534 | 9,407 | 7,695 | 6,590 |
| Accrued Expenses | 9,250 | 10,552 | 11,742 | 7,760 | 8,936 |
| Other current liabilities | 10,588 | 10,253 | 10,279 | 10,404 | 1,107 |
| TOTAL | $38,135 | $35,884 | $33,500 | $27,908 | $18,659 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 18,917 | 18,601 | 4,830 | 5,278 | 14,729 |
| TOTAL | $22,529 | $22,220 | $8,456 | $8,910 | $18,367 |
| Total Liabilities | $60,664 | $58,104 | $41,956 | $36,818 | $37,026 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 512 | 511 | 496 | 485 | 484 |
| Common Shares | 31 | 3 | 30 | 29 | 29 |
| Retained earnings | -385,839 | -348,715 | -310,038 | -278,229 | -246,071 |
| Other shareholders' equity | -665 | -1,124 | -1,822 | -1,918 | -1,637 |
| TOTAL | $231,487 | $249,398 | $281,742 | $284,734 | $311,185 |
| Total Liabilities And Equity | $292,151 | $307,502 | $323,698 | $321,552 | $348,211 |